Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Rosuvastatin Coadministration in Hypertension and Hyperlipidemia
NCT01918332Phase 3Completed
- Sponsor
- LG Chem
- Start
- Apr 2012
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by LG Chem. Started Apr 2012; status: completed.
02
Drugs
valsartanrosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT01918332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918332.